If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...

Despite being off-patent for many years, Humalog and other insulin brands continue to make high sales, with Lilly booking around $3 billion from its product last year, $1.8 billion of which was ...

Why prices were driven up A British Medical Journal ... is that the products which will have their price cut, such as Humalog (insulin lispro), are already seeing their sales fall significantly.

In reality, patients pay much lower net prices. After all rebates and discounts are tallied, the typical patient today pays $5 per vial of Humalog, a popular insulin, and just $3.40 for its ...

Business Insider reached out to the three main insulin makers for comment, and two responded: "Every health care system is unique. In Canada, the government caps prices at very low levels ...